← Leaderboards
Boro Dropulic
Virxsys Corporation
$7,828,495
Attributed
$7,828,495
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2005–12$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$7,828,495 · 11
By mechanism
R44$5,581,012 · 2
R43$1,701,560 · 8
U19$545,923 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Safety”
- David Heimbrook · Leidos Biomedical Research, Inc.$398,099,186
- Lawrence Corey · Fred Hutchinson Cancer Center$396,952,463
- Mitchell J Malone · Texas A&M Research Foundation$329,191,208
- Gary D Acton · University Of California-Davis$320,373,312
- Melynda Holmes · Technical Resources Inc$232,659,786
- Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316
Research focus
SafetyBaseVectorClinical ResearchLentivirus VectorProtocols DocumentationLaboratoriesT-LymphocyteUniversitiesCellsClinical TrialsIn VitroTransduction EfficiencyGenesT-Cell ReceptorReportingEvaluationRetroviral VectorTechnologyLeadMalignant NeoplasmsIn VivoAntigensPeptides
Grant awards (15)
Clinical Vector for TCR Immunotherapy Targeted to Melanoma$1,729,819
R44 · FY2012 · CA · contact PI
Clinical Vector for TCR Immunotherapy Targeted to Melanoma$2,160,774
R44 · FY2011 · CA · contact PI
Clinical Vector for TCR Immunotherapy Targeted to Melanoma$1,191,796
R44 · FY2010 · CA · contact PI
A Novel Method of Generating Hepatitis C Virus-Like Particles using Lentivirus$282,918
R43 · FY2009 · AI · contact PI
Lentiviral expressed growth factors as a novel therapy in wound healing$119,144
R43 · FY2008 · AR · contact PI
Lentiviral Vectors for TCR Immunotherapy Targeted to HCV$289,677
R43 · FY2007 · AI · contact PI
cGMP and cGLP Lentiviral Vetors$193,902
U19 · FY2007 · AI · contact PI
T cell receptor gene vectors for EBV disease$134,081
R43 · FY2007 · CA · contact PI
Lentiviral Vectors for TCR Immunotherapy Targeted to melanoma$243,003
R43 · FY2006 · CA · contact PI
cGMP and cGLP Lentiviral Vetors$241,342
U19 · FY2006 · AI · contact PI
Lentiviral engineered T cell immunotherapy in tumors overexpressing mesothelin$236,588
R43 · FY2006 · CA · contact PI
Immunotherapy of CLL with lentiviral expressed CD40-ligand$114,645
R43 · FY2006 · CA · contact PI
cGMP and cGLP Lentiviral Vetors$110,679
U19 · FY2005 · AI
HIV-1 vector mediated gene therapy for HIV-1 infection$498,623
R44 · FY2004 · AI
HIV-1 vector mediated gene therapy for HIV-1 infection$281,504
R43 · FY2002 · AI